Clinical Trials Logo

Pre-eclampsia clinical trials

View clinical trials related to Pre-eclampsia.

Filter by:

NCT ID: NCT01906567 Recruiting - Severe Preeclampsia Clinical Trials

İs There a Relationship Between Severity of Preeclampsia and Maternal Heavy Metal Levels?

Start date: July 2013
Phase: N/A
Study type: Observational [Patient Registry]

The purpose of this study, to investigate whether severity of preeclampsia is associated with altered levels of heavy metals (Cd, Hg, arsenic and Pb) in maternal blood, fetal blood, and maternal hair.

NCT ID: NCT01891240 Recruiting - Pregnancy Clinical Trials

IMproved PRegnancy Outcome by Early Detection

IMPROvED
Start date: November 2013
Phase: N/A
Study type: Observational

The overall objective of the IMPROvED project is to develop a sensitive, specific, high-throughput and economically viable early pregnancy screening test for preeclampsia. This will involve a multicentre, phase IIa clinical predictive study to assess and refine novel and innovative prototype tests based on emerging metabolomic and proteomic technologies developed by SMEs (small to medium size enterprise) within the consortium. The study will i) recruit 5000 first-time pregnant women; ii) establish a high calibre biobank, augmented by accurate clinical metadata; iii) determine whether prototype predictive assays and algorithms translate to the clinical environment; iv) assess potential synergy of a combined metabolomic and proteomic approach and v) progress regulatory approval and development of the selected test into the clinical arena.

NCT ID: NCT01888770 Recruiting - Preterm Birth Clinical Trials

The Effect of Prematurity and Hypertensive Disorders of Pregnancy on Offspring Cardiovascular Health

EPOCH
Start date: August 2011
Phase: N/A
Study type: Observational

The purpose of this study is to investigate whether exposure to hypertensive disorders of pregnancy and/or a preterm birth results in alterations in the cardiovascular system during infancy.

NCT ID: NCT01856387 Recruiting - Preeclampsia Clinical Trials

The Effect of neutrophil-to Lymphocyte Ratio in Preeclampsia- Eclampsia

Start date: May 2013
Phase: N/A
Study type: Observational

Neutrophil/lymphocyte ratio (NLR) is a marker of systemic inflammation and endothelial dysfunction. In recent years, it has been reported that the individual components of the differential white cell count, specifically the neutrophil and lymphocyte counts,may have clinical utility in predicting diseases. An elevated NLR has been shown to be a prognostic indicator in various malignancies. İn the literature, many studies have been shown that NLR have predictive value in determining the prognosis of various diseases (cardiac or noncardiac diseases ). However, little is known about the predictive values of NLR in pregnancy complications. This study aimed to evaluate the potential predictive value of NLR in preeclampsia- eclampsia.

NCT ID: NCT01806454 Recruiting - Preeclampsia Clinical Trials

Calcium Supplementation to Prevent Preeclampsia in Sichuan Province of China

Start date: October 2013
Phase: N/A
Study type: Interventional

the purpose of this study is to determine whether calcium supplementation is effective to prevent preeclampsia in Sichuang Province of china and which dose is more suitable

NCT ID: NCT01630772 Recruiting - Preeclampsia Clinical Trials

Physical Therapy in Pregnant Women With Preeclampsia

FPE
Start date: June 2012
Phase: Phase 1/Phase 2
Study type: Interventional

The aim of this study is to evaluate the influence that has a physical therapy protocol in maternal and fetal hemodynamics in relation to blood pressure, maternal and fetal responses and perinatal outcomes.

NCT ID: NCT01523327 Recruiting - Clinical trials for Uric Acid and Hypertension in Pregnancy

Study of Association Between Maternal Uric Acid , Maternal and Fetal Outcome in Pregnant Women With Hypertension

Start date: October 2011
Phase: N/A
Study type: Observational

Association of maternal uric acid with maternal condition and fetal outcome in pregnant women with hypertension.

NCT ID: NCT01382732 Recruiting - Clinical trials for Postpartum Hemorrhage

Carbetocin vs. Oxytocin for Prevention of Postpartum Bleeding in Patients With Severe Preeclampsia

Start date: January 2012
Phase: Phase 3
Study type: Interventional

Postpartum hemorrhage is an important cause of maternal morbidity and mortality. In patients with severe preeclampsia there is an increased risk of postpartum hemorrhage but the hemodynamic changes associated with this pathology make the management of any kind of bleeding particularly troublesome. There are many pharmacological options, being oxytocin the first line of treatment. However there is no evidence about the safety and efficacy of carbetocin, an oxytocin agonist. The investigators aimed to compare oxytocin with carbetocin for the routine prevention of postpartum hemorrhage in patients with severe preeclampsia.

NCT ID: NCT01374477 Recruiting - Preeclampsia Clinical Trials

Hypertensive Disorders of Pregnancy in Adolescence and Primipaternity

Start date: June 2012
Phase: N/A
Study type: Observational

Hypertensive disorders of pregnancy are one of the most frequent complications of pregnancy, being a serious health problem around the world. Previous studies have suggested that there is an association between a short period of exposure to paternal sperm of a new sexual partner and the development of an immunological reaction that could trigger a hypertensive disorder of pregnancy. For this reason we want to study the relationship between the primipaternity concept (exposure to male antigens present in semen over a short period of time previous to the pregnancy) and the development of preeclampsia in adolescents.

NCT ID: NCT01361425 Recruiting - Preeclampsia Clinical Trials

Anti-Hypertensive Treatment In Stable Pregnant Women With Severe Pre-Eclampsia (Metildopape)

METILDOPAPE
Start date: May 2011
Phase: Phase 4
Study type: Interventional

Introduction: Hypertensive emergency in pregnant women with pre-eclampsia should be treated for preventing stroke and placental abruption. However, the benefit of antihypertensive medication maintenance remains unclear, mainly due to the potential risk of fetal growth restriction.